HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,256 | +5.9% | 7,991 | 0.0% | 0.11% | +14.3% |
| Q2 2023 | $288,235 | +43.6% | 7,991 | +52.1% | 0.10% | +32.4% |
| Q1 2023 | $200,688 | -34.6% | 5,255 | -32.4% | 0.07% | -45.6% |
| Q3 2022 | $307,000 | +12.5% | 7,769 | +25.3% | 0.14% | +20.4% |
| Q2 2022 | $273,000 | +33.8% | 6,199 | +21.4% | 0.11% | +63.8% |
| Q1 2022 | $204,000 | -11.3% | 5,108 | -10.6% | 0.07% | 0.0% |
| Q4 2021 | $230,000 | -0.9% | 5,712 | 0.0% | 0.07% | -5.5% |
| Q3 2021 | $232,000 | -10.4% | 5,712 | 0.0% | 0.07% | -8.8% |
| Q2 2021 | $259,000 | +8.8% | 5,712 | 0.0% | 0.08% | +6.7% |
| Q1 2021 | $238,000 | – | 5,712 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |